Global Oral Live Cholera Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Oral Live Cholera Vaccines market size was valued at USD 87 million in 2023 and is forecast to a readjusted size of USD 137.6 million by 2030 with a CAGR of 6.7% during review period.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
The Global Info Research report includes an overview of the development of the Oral Live Cholera Vaccines industry chain, the market status of Prevention (Euvichol- Plus, DUKORAL), Emergency Response (Euvichol- Plus, DUKORAL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Live Cholera Vaccines.
Regionally, the report analyzes the Oral Live Cholera Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Live Cholera Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Live Cholera Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Live Cholera Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Euvichol- Plus, DUKORAL).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Live Cholera Vaccines market.
Regional Analysis: The report involves examining the Oral Live Cholera Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Live Cholera Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Live Cholera Vaccines:
Company Analysis: Report covers individual Oral Live Cholera Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Live Cholera Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prevention, Emergency Response).
Technology Analysis: Report covers specific technologies relevant to Oral Live Cholera Vaccines. It assesses the current state, advancements, and potential future developments in Oral Live Cholera Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Live Cholera Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Live Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Oral Live Cholera Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Live Cholera Vaccines, with price, sales, revenue and global market share of Oral Live Cholera Vaccines from 2019 to 2024.
Chapter 3, the Oral Live Cholera Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Live Cholera Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Live Cholera Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Live Cholera Vaccines.
Chapter 14 and 15, to describe Oral Live Cholera Vaccines sales channel, distributors, customers, research findings and conclusion.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
The Global Info Research report includes an overview of the development of the Oral Live Cholera Vaccines industry chain, the market status of Prevention (Euvichol- Plus, DUKORAL), Emergency Response (Euvichol- Plus, DUKORAL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Live Cholera Vaccines.
Regionally, the report analyzes the Oral Live Cholera Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Live Cholera Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Live Cholera Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Live Cholera Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Euvichol- Plus, DUKORAL).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Live Cholera Vaccines market.
Regional Analysis: The report involves examining the Oral Live Cholera Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Live Cholera Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Live Cholera Vaccines:
Company Analysis: Report covers individual Oral Live Cholera Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Live Cholera Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prevention, Emergency Response).
Technology Analysis: Report covers specific technologies relevant to Oral Live Cholera Vaccines. It assesses the current state, advancements, and potential future developments in Oral Live Cholera Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Live Cholera Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Live Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Euvichol- Plus
- DUKORAL
- Shanchol
- Others
- Prevention
- Emergency Response
- PaxVax
- Sanofi
- Valneva
- EuBiologics
- Shanghai United Cell Biotechnology
- Vabiotech
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Oral Live Cholera Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Live Cholera Vaccines, with price, sales, revenue and global market share of Oral Live Cholera Vaccines from 2019 to 2024.
Chapter 3, the Oral Live Cholera Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Live Cholera Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Live Cholera Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Live Cholera Vaccines.
Chapter 14 and 15, to describe Oral Live Cholera Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oral Live Cholera Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Live Cholera Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Euvichol- Plus
1.3.3 DUKORAL
1.3.4 Shanchol
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Live Cholera Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prevention
1.4.3 Emergency Response
1.5 Global Oral Live Cholera Vaccines Market Size & Forecast
1.5.1 Global Oral Live Cholera Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oral Live Cholera Vaccines Sales Quantity (2019-2030)
1.5.3 Global Oral Live Cholera Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Oral Live Cholera Vaccines Product and Services
2.1.4 PaxVax Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PaxVax Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Oral Live Cholera Vaccines Product and Services
2.2.4 Sanofi Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Oral Live Cholera Vaccines Product and Services
2.3.4 Valneva Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva Recent Developments/Updates
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Oral Live Cholera Vaccines Product and Services
2.4.4 EuBiologics Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EuBiologics Recent Developments/Updates
2.5 Shanghai United Cell Biotechnology
2.5.1 Shanghai United Cell Biotechnology Details
2.5.2 Shanghai United Cell Biotechnology Major Business
2.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product and Services
2.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
2.6 Vabiotech
2.6.1 Vabiotech Details
2.6.2 Vabiotech Major Business
2.6.3 Vabiotech Oral Live Cholera Vaccines Product and Services
2.6.4 Vabiotech Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Vabiotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ORAL LIVE CHOLERA VACCINES BY MANUFACTURER
3.1 Global Oral Live Cholera Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oral Live Cholera Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Oral Live Cholera Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oral Live Cholera Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oral Live Cholera Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Oral Live Cholera Vaccines Manufacturer Market Share in 2023
3.5 Oral Live Cholera Vaccines Market: Overall Company Footprint Analysis
3.5.1 Oral Live Cholera Vaccines Market: Region Footprint
3.5.2 Oral Live Cholera Vaccines Market: Company Product Type Footprint
3.5.3 Oral Live Cholera Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oral Live Cholera Vaccines Market Size by Region
4.1.1 Global Oral Live Cholera Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Oral Live Cholera Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Oral Live Cholera Vaccines Average Price by Region (2019-2030)
4.2 North America Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.3 Europe Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.5 South America Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Oral Live Cholera Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Oral Live Cholera Vaccines Consumption Value by Type (2019-2030)
5.3 Global Oral Live Cholera Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Oral Live Cholera Vaccines Consumption Value by Application (2019-2030)
6.3 Global Oral Live Cholera Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Oral Live Cholera Vaccines Market Size by Country
7.3.1 North America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Oral Live Cholera Vaccines Market Size by Country
8.3.1 Europe Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oral Live Cholera Vaccines Market Size by Region
9.3.1 Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oral Live Cholera Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Oral Live Cholera Vaccines Market Size by Country
10.3.1 South America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oral Live Cholera Vaccines Market Size by Country
11.3.1 Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Oral Live Cholera Vaccines Market Drivers
12.2 Oral Live Cholera Vaccines Market Restraints
12.3 Oral Live Cholera Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oral Live Cholera Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Live Cholera Vaccines
13.3 Oral Live Cholera Vaccines Production Process
13.4 Oral Live Cholera Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Live Cholera Vaccines Typical Distributors
14.3 Oral Live Cholera Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Oral Live Cholera Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Live Cholera Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Euvichol- Plus
1.3.3 DUKORAL
1.3.4 Shanchol
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Live Cholera Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prevention
1.4.3 Emergency Response
1.5 Global Oral Live Cholera Vaccines Market Size & Forecast
1.5.1 Global Oral Live Cholera Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oral Live Cholera Vaccines Sales Quantity (2019-2030)
1.5.3 Global Oral Live Cholera Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Oral Live Cholera Vaccines Product and Services
2.1.4 PaxVax Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PaxVax Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Oral Live Cholera Vaccines Product and Services
2.2.4 Sanofi Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Oral Live Cholera Vaccines Product and Services
2.3.4 Valneva Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva Recent Developments/Updates
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Oral Live Cholera Vaccines Product and Services
2.4.4 EuBiologics Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EuBiologics Recent Developments/Updates
2.5 Shanghai United Cell Biotechnology
2.5.1 Shanghai United Cell Biotechnology Details
2.5.2 Shanghai United Cell Biotechnology Major Business
2.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product and Services
2.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
2.6 Vabiotech
2.6.1 Vabiotech Details
2.6.2 Vabiotech Major Business
2.6.3 Vabiotech Oral Live Cholera Vaccines Product and Services
2.6.4 Vabiotech Oral Live Cholera Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Vabiotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ORAL LIVE CHOLERA VACCINES BY MANUFACTURER
3.1 Global Oral Live Cholera Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oral Live Cholera Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Oral Live Cholera Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oral Live Cholera Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oral Live Cholera Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Oral Live Cholera Vaccines Manufacturer Market Share in 2023
3.5 Oral Live Cholera Vaccines Market: Overall Company Footprint Analysis
3.5.1 Oral Live Cholera Vaccines Market: Region Footprint
3.5.2 Oral Live Cholera Vaccines Market: Company Product Type Footprint
3.5.3 Oral Live Cholera Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oral Live Cholera Vaccines Market Size by Region
4.1.1 Global Oral Live Cholera Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Oral Live Cholera Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Oral Live Cholera Vaccines Average Price by Region (2019-2030)
4.2 North America Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.3 Europe Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.5 South America Oral Live Cholera Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Oral Live Cholera Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Oral Live Cholera Vaccines Consumption Value by Type (2019-2030)
5.3 Global Oral Live Cholera Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Oral Live Cholera Vaccines Consumption Value by Application (2019-2030)
6.3 Global Oral Live Cholera Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Oral Live Cholera Vaccines Market Size by Country
7.3.1 North America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Oral Live Cholera Vaccines Market Size by Country
8.3.1 Europe Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oral Live Cholera Vaccines Market Size by Region
9.3.1 Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oral Live Cholera Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Oral Live Cholera Vaccines Market Size by Country
10.3.1 South America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oral Live Cholera Vaccines Market Size by Country
11.3.1 Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oral Live Cholera Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Oral Live Cholera Vaccines Market Drivers
12.2 Oral Live Cholera Vaccines Market Restraints
12.3 Oral Live Cholera Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oral Live Cholera Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Live Cholera Vaccines
13.3 Oral Live Cholera Vaccines Production Process
13.4 Oral Live Cholera Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Live Cholera Vaccines Typical Distributors
14.3 Oral Live Cholera Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Oral Live Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oral Live Cholera Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Oral Live Cholera Vaccines Product and Services
Table 6. PaxVax Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PaxVax Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Oral Live Cholera Vaccines Product and Services
Table 11. Sanofi Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Valneva Basic Information, Manufacturing Base and Competitors
Table 14. Valneva Major Business
Table 15. Valneva Oral Live Cholera Vaccines Product and Services
Table 16. Valneva Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Valneva Recent Developments/Updates
Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 19. EuBiologics Major Business
Table 20. EuBiologics Oral Live Cholera Vaccines Product and Services
Table 21. EuBiologics Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EuBiologics Recent Developments/Updates
Table 23. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai United Cell Biotechnology Major Business
Table 25. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product and Services
Table 26. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 29. Vabiotech Major Business
Table 30. Vabiotech Oral Live Cholera Vaccines Product and Services
Table 31. Vabiotech Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Vabiotech Recent Developments/Updates
Table 33. Global Oral Live Cholera Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Oral Live Cholera Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Oral Live Cholera Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Oral Live Cholera Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Oral Live Cholera Vaccines Production Site of Key Manufacturer
Table 38. Oral Live Cholera Vaccines Market: Company Product Type Footprint
Table 39. Oral Live Cholera Vaccines Market: Company Product Application Footprint
Table 40. Oral Live Cholera Vaccines New Market Entrants and Barriers to Market Entry
Table 41. Oral Live Cholera Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Oral Live Cholera Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Oral Live Cholera Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Oral Live Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Oral Live Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Oral Live Cholera Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Oral Live Cholera Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Oral Live Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Oral Live Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Oral Live Cholera Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Oral Live Cholera Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Oral Live Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Oral Live Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Oral Live Cholera Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Oral Live Cholera Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Oral Live Cholera Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Oral Live Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Oral Live Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Oral Live Cholera Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Oral Live Cholera Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Oral Live Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Oral Live Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Oral Live Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Oral Live Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Oral Live Cholera Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Oral Live Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Oral Live Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Oral Live Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Oral Live Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Oral Live Cholera Vaccines Raw Material
Table 101. Key Manufacturers of Oral Live Cholera Vaccines Raw Materials
Table 102. Oral Live Cholera Vaccines Typical Distributors
Table 103. Oral Live Cholera Vaccines Typical Customers
Table 1. Global Oral Live Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oral Live Cholera Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Oral Live Cholera Vaccines Product and Services
Table 6. PaxVax Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PaxVax Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Oral Live Cholera Vaccines Product and Services
Table 11. Sanofi Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Valneva Basic Information, Manufacturing Base and Competitors
Table 14. Valneva Major Business
Table 15. Valneva Oral Live Cholera Vaccines Product and Services
Table 16. Valneva Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Valneva Recent Developments/Updates
Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 19. EuBiologics Major Business
Table 20. EuBiologics Oral Live Cholera Vaccines Product and Services
Table 21. EuBiologics Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EuBiologics Recent Developments/Updates
Table 23. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai United Cell Biotechnology Major Business
Table 25. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product and Services
Table 26. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 29. Vabiotech Major Business
Table 30. Vabiotech Oral Live Cholera Vaccines Product and Services
Table 31. Vabiotech Oral Live Cholera Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Vabiotech Recent Developments/Updates
Table 33. Global Oral Live Cholera Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Oral Live Cholera Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Oral Live Cholera Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Oral Live Cholera Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Oral Live Cholera Vaccines Production Site of Key Manufacturer
Table 38. Oral Live Cholera Vaccines Market: Company Product Type Footprint
Table 39. Oral Live Cholera Vaccines Market: Company Product Application Footprint
Table 40. Oral Live Cholera Vaccines New Market Entrants and Barriers to Market Entry
Table 41. Oral Live Cholera Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Oral Live Cholera Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Oral Live Cholera Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Oral Live Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Oral Live Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Oral Live Cholera Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Oral Live Cholera Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Oral Live Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Oral Live Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Oral Live Cholera Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Oral Live Cholera Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Oral Live Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Oral Live Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Oral Live Cholera Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Oral Live Cholera Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Oral Live Cholera Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Oral Live Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Oral Live Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Oral Live Cholera Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Oral Live Cholera Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Oral Live Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Oral Live Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Oral Live Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Oral Live Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Oral Live Cholera Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Oral Live Cholera Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Oral Live Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Oral Live Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Oral Live Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Oral Live Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Oral Live Cholera Vaccines Raw Material
Table 101. Key Manufacturers of Oral Live Cholera Vaccines Raw Materials
Table 102. Oral Live Cholera Vaccines Typical Distributors
Table 103. Oral Live Cholera Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Oral Live Cholera Vaccines Picture
Figure 2. Global Oral Live Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oral Live Cholera Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Euvichol- Plus Examples
Figure 5. DUKORAL Examples
Figure 6. Shanchol Examples
Figure 7. Others Examples
Figure 8. Global Oral Live Cholera Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Oral Live Cholera Vaccines Consumption Value Market Share by Application in 2023
Figure 10. Prevention Examples
Figure 11. Emergency Response Examples
Figure 12. Global Oral Live Cholera Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Oral Live Cholera Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Oral Live Cholera Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Oral Live Cholera Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Oral Live Cholera Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Oral Live Cholera Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Oral Live Cholera Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Oral Live Cholera Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Oral Live Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Oral Live Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Oral Live Cholera Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Oral Live Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Oral Live Cholera Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Oral Live Cholera Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Oral Live Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Oral Live Cholera Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Oral Live Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Oral Live Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Oral Live Cholera Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Oral Live Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Oral Live Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Oral Live Cholera Vaccines Market Drivers
Figure 75. Oral Live Cholera Vaccines Market Restraints
Figure 76. Oral Live Cholera Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Oral Live Cholera Vaccines
Figure 80. Oral Live Cholera Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Oral Live Cholera Vaccines Picture
Figure 2. Global Oral Live Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oral Live Cholera Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Euvichol- Plus Examples
Figure 5. DUKORAL Examples
Figure 6. Shanchol Examples
Figure 7. Others Examples
Figure 8. Global Oral Live Cholera Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Oral Live Cholera Vaccines Consumption Value Market Share by Application in 2023
Figure 10. Prevention Examples
Figure 11. Emergency Response Examples
Figure 12. Global Oral Live Cholera Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Oral Live Cholera Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Oral Live Cholera Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Oral Live Cholera Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Oral Live Cholera Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Oral Live Cholera Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Oral Live Cholera Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Oral Live Cholera Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Oral Live Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Oral Live Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Oral Live Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Oral Live Cholera Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Oral Live Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Oral Live Cholera Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Oral Live Cholera Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Oral Live Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Oral Live Cholera Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Oral Live Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Oral Live Cholera Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Oral Live Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Oral Live Cholera Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Oral Live Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Oral Live Cholera Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Oral Live Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Oral Live Cholera Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Oral Live Cholera Vaccines Market Drivers
Figure 75. Oral Live Cholera Vaccines Market Restraints
Figure 76. Oral Live Cholera Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Oral Live Cholera Vaccines
Figure 80. Oral Live Cholera Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
